Rockwell Medical, Inc.
RMTI· Nasdaq
Filed Mar 18, 2019 · 10-K · 77 days after period end · 0001558370-19-002200
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $16.85M | $14.84M | $13.39M | $14.13M |
| Net Income | -$9.38M | -$9.04M | -$5.05M | -$5.77M |
| EPS Diluted | — | -$0.18 | -$0.10 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 18, 2019 · 77 d after period end